Prosensa strength­ens its man­age­ment team – Berndt Modig appoint­ed as Chief Financial Officer

Leiden, March 17, 2010 – Prosensa, the Dutch based bio­phar­ma­ceu­ti­cal com­pa­ny focus­ing on RNA mod­u­lat­ing ther­a­peu­tics, announces the appoint­ment of Berndt Modig as Chief Financial Officer (CFO).

Berndt Modig (51) brings more than 20 years of inter­na­tion­al expe­ri­ence in com­pa­ny finance to Prosensa. In his pre­vi­ous posi­tion as CFO of Jerini AG, a German drug dis­cov­ery and devel­op­ment com­pa­ny, he man­aged sev­er­al financ­ing oper­a­tions, includ­ing the company’s IPO on the Frankfurt stock exchange. He also co-ordi­nat­ed the acqui­si­tion of Jerini by Shire. Before this, Berndt was CFO at Surplex AG and Finance Director Europe of Hayward Industrial Products GmbH, a European sub­sidiary of Hayward Industries Inc. As co-founder and part­ner in Agra Industria Sprl and invest­ment man­ag­er at IMM GmbH he gained expe­ri­ence in pri­vate equi­ty. He start­ed his career at Price Waterhouse in the US where he held sev­er­al posi­tions in the Financial Services Group. Berndt has a Bachelor degree in Business Administration, Economics and German from the University of Lund, Sweden, an MBA from INSEAD, France and is a Certified Public Accountant.

“We con­tin­ue to build a strong multi­na­tion­al man­age­ment team at Prosensa to sup­port our growth strat­e­gy. With his dis­tin­guished track record of suc­cess­ful­ly build­ing val­ue in the pri­vate and pub­lic are­na, Berndt has the right exper­tise to help us exe­cute our busi­ness objec­tive of becom­ing a lead­ing provider of ther­a­peu­tic solu­tions for rare neu­ro­mus­cu­lar dis­or­ders” said Hans Schikan, CEO of Prosensa.

Commenting on his new appoint­ment, Berndt Modig said: “Prosensa is an excit­ing biotech­nol­o­gy com­pa­ny with great poten­tial. I look for­ward to the oppor­tu­ni­ty of work­ing with the team to cre­ate sig­nif­i­cant val­ue for its share­hold­ers as the com­pa­ny devel­ops into a lead­ing bio­phar­ma­ceu­ti­cal com­pa­ny.”

Leave a Reply

Your email address will not be published. Required fields are marked *